Publication:
Serum cytokine and T regulatory cell levels in patients with burning mouth syndrome

dc.contributor.authorGÜMRÜ TARÇIN, BİRSAY
dc.contributor.authorNAMDAR PEKİNER, FİLİZ MEDİHA
dc.contributor.authorsPekiner, Filiz Namdar; Demirel, Guelderen Yamkkaya; Gumru, Birsay; Ozbayrak, Semih
dc.date.accessioned2022-03-12T17:34:02Z
dc.date.accessioned2026-01-11T07:02:06Z
dc.date.available2022-03-12T17:34:02Z
dc.date.issued2008
dc.description.abstractBACKGROUND: Burning mouth syndrome is a disorder usually associated with an unexplained, prolonged sensation of burning inside the oral cavity. Although the etiology is unknown, neural and psychologic factors and cytokines may be implicated in the pathogenesis of burning mouth syndrome. The aim of this study was to investigate the relationship between serum cytokine and T regulatory cell levels in patients with burning mouth syndrome with regard to depression and anxiety. METHODS: Thirty patients with burning mouth syndrome and 30 matched controls participated in the study. Serum cytokine levels were measured with cytometric bead array and T regulatory cells were defined as CD4(+)CD25(+)Foxp-3(+) cells by flow cytometry. The level of anxiety and depression were analyzed by means of the Speilberger State-Trait Anxiety Inventory and Zung Self-Rating Depression Scale. Visual analogue scale was used in the quantification of burning levels of patients. RESULTS: Serum IL-2 and TNF-alpha levels were significantly decreased in patients with burning mouth syndrome compared with controls [mean 16.79 +/- 8.70 vs. 37.73 +/- 41.05 pg/ml (P < 0.05) and mean 39.09 +/- 29.40 vs. 70.83 +/- 42.44 pg/ml (P < 0.01) respectively]. CONCLUSIONS: IL-2 and TNF-alpha might play a role in burning mouth syndrome. Burning mouth syndrome may occur as a sign of predisposition to autoimmunity. Presence of low levels of CD28(+) supports the provision that BMS might be a pre-otoimmune disease.
dc.identifier.doi10.1111/j.1600-0714.2008.00668.x
dc.identifier.eissn1600-0714
dc.identifier.issn0904-2512
dc.identifier.pubmed18624934
dc.identifier.urihttps://hdl.handle.net/11424/228958
dc.identifier.wosWOS:000259026500004
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofJOURNAL OF ORAL PATHOLOGY & MEDICINE
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectburning mouth syndrome
dc.subjectcytokine
dc.subjectserum
dc.subjectT regulatory cell
dc.subjectSELF-TOLERANCE
dc.subjectIN-VITRO
dc.subjectACTIVATION
dc.subjectDEPRESSION
dc.subjectINTERLEUKIN-6
dc.subjectAUTOIMMUNITY
dc.subjectSYMPTOMS
dc.subjectALPHA
dc.subjectIL-2
dc.titleSerum cytokine and T regulatory cell levels in patients with burning mouth syndrome
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage534
oaire.citation.issue9
oaire.citation.startPage528
oaire.citation.titleJOURNAL OF ORAL PATHOLOGY & MEDICINE
oaire.citation.volume37

Files